促销计划的规则是伤害我们的同事、学员,和病人。展示公司幻灯片甲板上用更适合的消息由医药代表销售的讨论就可以得到。然而,正如马丁博士指出,“教师看到赚取额外收入的机会。”We believe the pharmaceutical industry supports programs to enhance sales and also to educate physicians for the ultimate benefit of patients.
博士Benbadis Cyberonics作为顾问或扬声器,葛兰素史克,Lundbeck公司,它是一家辉瑞Sleepmed, UCB制药,XLTEKl。Faught博士作为顾问卫材和鼓掌;接收来自疾病控制中心的研究支持和葛兰素史克公司;先前的研究支持卫材、约翰逊和约翰逊,绿,和施瓦兹(UCB制药公司);他发言的雅培管理局、葛兰素史克、辉瑞、鼓掌和联合制药和接收谢礼为这些公司来说和咨询。Sirven博士曾在药制药公司的顾问委员会,Ikano和诺华;Neuropace UCB收到研究赔偿,所以和美国国立神经疾病和中风。Slater博士曾在扬声器的辉瑞公司的办事处,UCB Cyberonics;作为主要研究者在临床药物试验主办的联合;和服务于临床研究数据安全管理委员会由图标。 Dr. Sperling serves as Associate Editor of Epilepsia; received funding from the NIH; received research funding from UCB, Sepracor, Vertex, Marinus, Lundbeck and Eisai; and served on speakers' bureaus of UCB and Pfizer. Dr. Hirsch served on the scientific advisory boards for Lundbeck, Ikano Therapeutics and Jazz Pharmaceuticals; serves as an editorial board member for the Journal of Clinical Neurophysiology; served as a contributing editor for Epilepsy Currents; received royalties for “Atlas of EEG in Critical Care” and for neurology sections of UpToDate; received honoraria for serving on the speakers’ bureaus for GlaxoSmithKline, Pfizer, Lundbeck and UCB-Pharma; and received research support from Eisai, GlaxoSmithKline, the American Epilepsy Society and the Epilepsy Foundation.
我们为马丁解决复杂问题的利益冲突。[1]学术神经病学家教育者以及医生和许多不舒服使用教育项目的制药公司的幻灯片。
随着制药变得更规范,教师将使用未经审查的公司幻灯片。正如Martin博士指出的那样,这背后有许多原因,“是否以及在多大程度上营销努力应该也可以分开教育内容无疑将是未来的谷物的讨论。”
促销计划的规则是伤害我们的同事、学员,和病人。展示公司幻灯片甲板上用更适合的消息由医药代表销售的讨论就可以得到。然而,正如马丁博士指出,“教师看到赚取额外收入的机会。”We believe the pharmaceutical industry supports programs to enhance sales and also to educate physicians for the ultimate benefit of patients.
都应该有一个解决方案来满足工业和学术physicians-educators。这些项目可以填补一个教育空白医生不能定期参加与subspecialists神经学大查房和几乎没有交互。首页没有讨论和政策的变化,著名的教员将开始仅仅参加继续医学教育(CME)事件。许多个人和机构不支持任何类型的促销活动与行业;有些教师只允许参与CME讲座。然而,正如马丁状态,公司支持CME事件引起人们的关注。
院士可以负责谈判的内容和公司签订一份弃权证书证明无罪。新类型的教育事件可以由两个部分组成,包括促销的一部分(幻灯片)之后或之前CME项目。一些公司已经开始探索这种可能性和毫无疑问其他合适的选项。通过与行业合作,各方利益。
参考
1。马丁·简森-巴顿。无处不在的infludence利益冲突。首页神经学2010;74:2016 - 2021。
编者按:这篇文章的作者提供了机会但拒绝作出回应。
披露的信息
博士Benbadis Cyberonics作为顾问或扬声器,葛兰素史克,Lundbeck公司,它是一家辉瑞Sleepmed, UCB制药,XLTEKl。Faught博士作为顾问卫材和鼓掌;接收来自疾病控制中心的研究支持和葛兰素史克公司;先前的研究支持卫材、约翰逊和约翰逊,绿,和施瓦兹(UCB制药公司);他发言的雅培管理局、葛兰素史克、辉瑞、鼓掌和联合制药和接收谢礼为这些公司来说和咨询。Sirven博士曾在药制药公司的顾问委员会,Ikano和诺华;Neuropace UCB收到研究赔偿,所以和美国国立神经疾病和中风。Slater博士曾在扬声器的辉瑞公司的办事处,UCB Cyberonics;作为主要研究者在临床药物试验主办的联合;和服务于临床研究数据安全管理委员会由图标。 Dr. Sperling serves as Associate Editor of Epilepsia; received funding from the NIH; received research funding from UCB, Sepracor, Vertex, Marinus, Lundbeck and Eisai; and served on speakers' bureaus of UCB and Pfizer. Dr. Hirsch served on the scientific advisory boards for Lundbeck, Ikano Therapeutics and Jazz Pharmaceuticals; serves as an editorial board member for the Journal of Clinical Neurophysiology; served as a contributing editor for Epilepsy Currents; received royalties for “Atlas of EEG in Critical Care” and for neurology sections of UpToDate; received honoraria for serving on the speakers’ bureaus for GlaxoSmithKline, Pfizer, Lundbeck and UCB-Pharma; and received research support from Eisai, GlaxoSmithKline, the American Epilepsy Society and the Epilepsy Foundation.